Imran Rangraze

1. JANIĆ, Miodrag (avtor, korespondenčni avtor), JANEŽ, Andrej, ŠABOVIČ, Mišo, EL-TANANI, Mohamed, RANGRAZE, Imran, RIZZO, Manfredi, LUNDER, Mojca. Glucometabolic efficacy of the empagliflozin/metformin combination in people with type 1 diabetes and increased cardiovascular risk : a sub-analysis of a pilot randomized controlled trial. Journal of clinical medicine. 2024, vol. 13, iss. 22, str. 1-12, ilustr. ISSN 2077-0383. https://www.mdpi.com/2077-0383/13/22/6860, DiRROS - Digitalni repozitorij raziskovalnih organizacij Slovenije, Repozitorij Univerze v Ljubljani – RUL, DOI: 10.3390/jcm13226860. [COBISS.SI-ID 215249411]
projekt: financer: University Medical Centre Ljubljana,

2. RANGRAZE, Imran, EL-TANANI, Mohamed, JANEŽ, Andrej, MAGGIO, Viviana, RABBANI, Syed Arman, JENSTERLE SEVER, Mojca, MUNDA, Ana, ABBAS, Elhadi Eltayeb, ALI, Humam Sami, FAROOQI, Mohammad Rashid, PATNI, Mohamed Anas Faruk, RIZZO, Manfredi. Persistence-dependent effectiveness of tirzepatide on the cardio-metabolic-kidney syndrome outcomes in obesity : real-world evidence from the United Arab Emirates. Diabetes therapy. 2026, vol. , no. , str. ISSN 1869-6961. https://link.springer.com/article/10.1007/s13300-026-01868-2, DOI: 10.1007/s13300-026-01868-2. [COBISS.SI-ID 276566275]

3. JANIĆ, Miodrag, RABBANI, Syed Arman, EL-TANANI, Mohamed, RANGRAZE, Imran, JANEŽ, Andrej, MAGGIO, Viviana, RIZZO, Manfredi. Tirzepatide data : safety first is safety always!. Expert opinion on drug safety. 2026, vol. , no. , str. ISSN 1474-0338. https://www.tandfonline.com/doi/full/10.1080/14740338.2026.2681511, DOI: 10.1080/14740338.2026.2681511. [COBISS.SI-ID 279743747]